Answers are grounded in this paper and cite their sources.
In this issue of Blood, Sanders and coworkers define the pathophysiology of types 1, 2, and 3 von Willebrand disease (VWD) in the Willebrand in the Netherlands (WiN) study by using the ratios of von Willebrand factor propeptide (VWFpp) or factor VIII activity to VWF antigen.
No takes yet. Share an insight, caveat, or question.
Sandra L. Haberichter (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: